Earnings call Humana increased its full-year 2025 adjusted EPS guidance from ~$16.25 to ~$17, citing better-than-expected Medicare Advantage membership retention and strong CenterWell Pharmacy ...

Earnings call Humana delivered a stronger-than-expected Q2, raising its full-year 2025 EPS guidance from ~$16.25 to ~$17.00. Key drivers included better-than-expected Medicare Advantage (MA) retention ...

Humana Inc. reported its second-quarter 2025 earnings, revealing a robust performance driven by its CenterWell Pharmacy and Medicare Advantage memberships. Despite raising its full-year EPS outlook, ...

Humana ((HUM)) has held its Q3 earnings call. Read on for the main highlights of the call. Humana’s Earnings Call Reflects Positive Performance Amid Challenges Humana’s third quarter earnings call ...

Humana Inc. (HUM) reported a robust second quarter for 2025, surpassing analysts’ expectations with an earnings per share (EPS) of $6.27, compared to the forecasted $5.87. The company also exceeded ...

Refer to the "Footnotes" section included herein for further explanation of disclosures for Adjusted (non-GAAP) financial measures, as well as additional reconciliations. Click to enlarge Detailed ...

Humana Inc. (HUM) reported its third-quarter 2025 earnings, surpassing analyst expectations with an EPS of $3.24 compared to the forecasted $2.83, marking a 14.49% surprise. Revenue reached $32.65 ...

George Renaudin to Retire as Insurance Segment President by Q3 2026 Aaron Martin to Join as President of Medicare Advantage and Insurance Segment President Successor John Barger to Succeed Martin as ...